Abstract
Objective
We evaluated the reading & comprehension levels of Systemic Lupus Erythematosus (SLE) Patient educational materials (PEMs) available online, from both nonprofit and for-profit organizations.
Methods
We analyzed PEMs from four nonprofit organizations (American College of Rheumatology [ACR], Lupus Foundation of America [LFA], Lupus Research Alliance [LRA], Lupus Society of Illinois [LSI]) & three for-profit company’s platforms (Aurinia, AstraZeneca, GlaxoSmithKline [GSK]). Reading & comprehension scores were calculated using six standard tools, and comparisons were performed using one-way ANOVA & Tukey’s post-hoc analysis. A p-value ≤0.05 was considered statistically significant.
Results
The average Flesch–Kincaid Grade Level (FKGL) and Flesch Reading Ease Score (FRES) across all PEMs were 10.05 ± 0.70 and 52.68 ± 4.10, respectively. Materials from nonprofit organizations had a FKGL of 10.35 ± 0.88 and a FRES of 51.19 ± 4.91, indicating a reading level requiring 10th- to 12th-grade proficiency. For-profit organizations had a slightly lower FKGL of 9.98 ± 0.42 and a higher FRES of 54.35 ± 2.65. These differences were not statistically significant (p = 0.53 and 0.16). However, significant within-group differences were observed. Among nonprofits, PEMs from LFA had the most favorable readability metrics (FKGL 9.19 ± 0.44, FRES 58.34 ± 3.11), compared to ACR (10.64 ± 0.56, 49.81 ± 2.24), LRA (10.53 ± 0.61, 50.54 ± 2.69), and LSI (11.28 ± 0.45, 45.64 ± 2.03) (p < 0.01). Among for-profits, PEMs from Aurinia had significantly better readability scores (FKGL 9.59 ± 0.46, FRES 55.77 ± 3.05) than those from AstraZeneca (9.93 ± 0.38, 53.13 ± 2.48) and GSK (9.86 ± 0.25, 54.28 ± 2.16) (p < 0.001).
Conclusion
Most SLE patient education materials available online are written at or above a 10th-grade level. These findings highlight the urgent need to improve PEM readability to support patients with lower health literacy.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
